Collegium Pharmaceutical, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Stoughton MA United States (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2012
NCT01685684
First Marketed Drug
2008
tapentadol (nucynta)
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

COLLEGIUM PHARM INC